ESC 2024 AF

2024 ESC Guidelines for the management of atrial fibrillation

The 2024 ESC AF guideline reframes care around the AF-CARE pathway ([C]omorbidity and risk-factor management, [A]void stroke and thromboembolism, [R]educe symptoms by rate and rhythm control, [E]valuation and dynamic reassessment) and simplifies stroke risk to the sex-neutral CHA₂DS₂-VA score. The register's landmark AF trials are grouped below by AF-CARE theme.

This guideline cites 19 of the 199 landmark trials in our Cardiology register.

Source
Van Gelder IC, Rienstra M, et al. Eur Heart J. 2024;45(36):3314–3414. · European Heart Journal

Avoid stroke — anticoagulation6

  • 2024FRAIL-AFCardiology · AF · DOAC switchSafety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation
  • 2013ENGAGE AF-TIMI 48Cardiology · AF · AnticoagulationEffective Anticoagulation with Factor Xa Next Generation in AF
  • 2011ROCKET-AFCardiology · AF · AnticoagulationRivaroxaban Once-daily oral direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and embolism in AF
  • 2011ARISTOTLECardiology · AF · AnticoagulationApixaban for Reduction in Stroke and Other Thromboembolic Events in AF
  • 2009RE-LYCardiology · AF · AnticoagulationRandomized Evaluation of Long-term Anticoagulation Therapy
  • 1991SPAFCardiology · AF · antithromboticStroke Prevention in Atrial Fibrillation Study

Reduce symptoms — rate vs. early rhythm control6

  • 2021EARLY-AFCardiology · AF · AblationEarly Aggressive Invasive Intervention for Atrial Fibrillation
  • 2020EAST-AFNET 4Cardiology · AF · Rate vs rhythmEarly Treatment of Atrial Fibrillation for Stroke Prevention Trial
  • 2019CABANACardiology · AF · AblationCatheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation
  • 2018CASTLE-AFCardiology · AF · AblationCatheter Ablation versus Standard Conventional Therapy in Patients with LV Dysfunction and AF
  • 2010RACE IICardiology · AF · rate controlRate Control Efficacy in Permanent Atrial Fibrillation: Lenient Versus Strict Rate Control II
  • 2002AFFIRMCardiology · AF · Rate vs rhythmAtrial Fibrillation Follow-up Investigation of Rhythm Management

Catheter & surgical ablation2

  • 2023ADVENTCardiology · AF · AblationPulsed Field or Conventional Thermal Ablation for Paroxysmal Atrial Fibrillation
  • 2020PRAGUE-17Cardiology · AF · LAAOLeft Atrial Appendage Closure versus Novel Anticoagulation Agents in Atrial Fibrillation

Left atrial appendage occlusion2

  • 2021LAAOS IIICardiology · AF · surgical LAAOLeft Atrial Appendage Occlusion Study III
  • 2014PROTECT AFCardiology · AF · LAAOWatchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation

Device-detected / subclinical AF3

  • 2024ARTESiACardiology · AF · DOACApixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Subclinical Atrial Fibrillation
  • 2023NOAH-AFNET 6Cardiology · AF · DOACNon-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High-Rate Episodes
  • 2014CRYSTAL AFCardiology · AF · cardiac monitorCryptogenic Stroke and Underlying Atrial Fibrillation

Published since the guideline1

  • 2025OPTIONCardiology · AF · LAAOComparison of Anticoagulation With Left Atrial Appendage Closure After Atrial Fibrillation Ablation